ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

Teddy DeVita’s Courageous Fight Ends At Age 17

June 6, 1980

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005

Biomed Research Absent from Bush State of the Union.

January 26, 2007